Sun Life’s capital-light diversification, 19.1% ROE and expanding stop-loss and alternatives franchises support an attractive five-year upside case despite MFS outflows and execution risks.
Overview
Sun Life Financial is a diversified Toronto-headquartered financial-services group, chartered in 1865, with five reporting segments: Canada, the United States, Asia, Asset Management and Corporate. It earns a balanced mix of insurance premiums, asset-management and wealth fees, and investment income. The strategic story is a transition toward capital-light businesses, particularly SLC Management alternatives, workplace health and wealth, while maintaining exposure to protection markets. Q2 2026 underlying net income rose 11% to CAD 1,123 million, reported net income rose 41% to CAD 1,008 million, underlying EPS increased 13% to CAD 2.02, and revenue grew 7.5% to CAD 9.10 billion. Underlying ROE was 19.1% and LICAT was 145%. **Growth is increasingly supported by U.S. stop-loss, commercial dental and alternatives**, although MFS experienced USD 22.9 billion of outflows. The stock trades at 18.9x TTM P/E and 2.6x book. Consensus is Moderate Buy with an average target of CAD 114.21, while the report’s five-year probability-weighted target is USD 119.30. Near-term catalysts include commercial dental margin recovery, alternative-asset fundraising and stabilization of Asian protection volumes.